Click for best price
Hospital Acquired Pneumonia Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 2888.7 million
|
Forecast Market size by 2029 |
US$ 3191.8 million
|
| Growth Rate |
CAGR of 1.4% |
Number of Pages |
72 Pages |
Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48?72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Pneumonia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Pneumonia Drugs. This report contains market size and forecasts of Hospital Acquired Pneumonia Drugs in global, including the following market information:
Global Hospital Acquired Pneumonia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hospital Acquired Pneumonia Drugs Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Hospital Acquired Pneumonia Drugs companies in 2022 (%)
The global Hospital Acquired Pneumonia Drugs market was valued at US$ 2888.7 million in 2022 and is projected to reach US$ 3191.8 million by 2029, at a CAGR of 1.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Phase II Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Pneumonia Drugs include Basilea Pharmaceutica, Meiji Holdings, Cubist Pharmaceutical, Aridis Pharmaceutical, Valneva, Bayer, GlaxoSmithKline, Merck and Achaogen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital Acquired Pneumonia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Pneumonia Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, by Type, 2022 (%)
Phase II
Early Phase (Phase I & II)
Global Hospital Acquired Pneumonia Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce
Global Hospital Acquired Pneumonia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Pneumonia Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hospital Acquired Pneumonia Drugs revenues share in global market, 2022 (%)
Key companies Hospital Acquired Pneumonia Drugs sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Hospital Acquired Pneumonia Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Basilea Pharmaceutica
Meiji Holdings
Cubist Pharmaceutical
Aridis Pharmaceutical
Valneva
Bayer
GlaxoSmithKline
Merck
Achaogen
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital Acquired Pneumonia Drugs, market overview.
Chapter 2: Global Hospital Acquired Pneumonia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Hospital Acquired Pneumonia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital Acquired Pneumonia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hospital Acquired Pneumonia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hospital Acquired Pneumonia Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2888.7 million
|
| Forecast Market size by 2029 |
US$ 3191.8 million
|
| Growth Rate |
CAGR of 1.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Acquired Pneumonia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Pneumonia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Acquired Pneumonia Drugs Overall Market Size
2.1 Global Hospital Acquired Pneumonia Drugs Market Size: 2022 VS 2029
2.2 Global Hospital Acquired Pneumonia Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hospital Acquired Pneumonia Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hospital Acquired Pneumonia Drugs Players in Global Market
3.2 Top Global Hospital Acquired Pneumonia Drugs Companies Ranked by Revenue
3.3 Global Hospital Acquired Pneumonia Drugs Revenue by Companies
3.4 Global Hospital Acquired Pneumonia Drugs Sales by Companies
3.5 Global Hospital Acquired Pneumonia Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hospital Acquired Pneumonia Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hospital Acquired Pneumonia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hospital Acquired Pneumonia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Acquired Pneumonia Drugs Market Size Markets, 2022 & 2029
4.1.2 Phase II
4.1.3 Early Phase (Phase I & II)
4.2 By Type - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Pneumonia Drugs Revenue, 2018-2023
4.2.2 By Type - Global Hospital Acquired Pneumonia Drugs Revenue, 2024-2029
4.2.3 By Type - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
4.3.1 By Type - Global Hospital Acquired Pneumonia Drugs Sales, 2018-2023
4.3.2 By Type - Global Hospital Acquired Pneumonia Drugs Sales, 2024-2029
4.3.3 By Type - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Hospital Acquired Pneumonia Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Pneumonia Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Drug Store
5.1.5 E-Commerce
5.2 By Application - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Pneumonia Drugs Revenue, 2018-2023
5.2.2 By Application - Global Hospital Acquired Pneumonia Drugs Revenue, 2024-2029
5.2.3 By Application - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
5.3.1 By Application - Global Hospital Acquired Pneumonia Drugs Sales, 2018-2023
5.3.2 By Application - Global Hospital Acquired Pneumonia Drugs Sales, 2024-2029
5.3.3 By Application - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Hospital Acquired Pneumonia Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hospital Acquired Pneumonia Drugs Market Size, 2022 & 2029
6.2 By Region - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Pneumonia Drugs Revenue, 2018-2023
6.2.2 By Region - Global Hospital Acquired Pneumonia Drugs Revenue, 2024-2029
6.2.3 By Region - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
6.3.1 By Region - Global Hospital Acquired Pneumonia Drugs Sales, 2018-2023
6.3.2 By Region - Global Hospital Acquired Pneumonia Drugs Sales, 2024-2029
6.3.3 By Region - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hospital Acquired Pneumonia Drugs Revenue, 2018-2029
6.4.2 By Country - North America Hospital Acquired Pneumonia Drugs Sales, 2018-2029
6.4.3 US Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.4.4 Canada Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.4.5 Mexico Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Hospital Acquired Pneumonia Drugs Sales, 2018-2029
6.5.3 Germany Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.4 France Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.5 U.K. Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.6 Italy Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.7 Russia Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.5.9 Benelux Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Hospital Acquired Pneumonia Drugs Sales, 2018-2029
6.6.3 China Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.6.4 Japan Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.6.5 South Korea Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.6.7 India Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hospital Acquired Pneumonia Drugs Revenue, 2018-2029
6.7.2 By Country - South America Hospital Acquired Pneumonia Drugs Sales, 2018-2029
6.7.3 Brazil Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.7.4 Argentina Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, 2018-2029
6.8.3 Turkey Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.8.4 Israel Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
6.8.6 UAE Hospital Acquired Pneumonia Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Basilea Pharmaceutica
7.1.1 Basilea Pharmaceutica Company Summary
7.1.2 Basilea Pharmaceutica Business Overview
7.1.3 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Major Product Offerings
7.1.4 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Basilea Pharmaceutica Key News & Latest Developments
7.2 Meiji Holdings
7.2.1 Meiji Holdings Company Summary
7.2.2 Meiji Holdings Business Overview
7.2.3 Meiji Holdings Hospital Acquired Pneumonia Drugs Major Product Offerings
7.2.4 Meiji Holdings Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Meiji Holdings Key News & Latest Developments
7.3 Cubist Pharmaceutical
7.3.1 Cubist Pharmaceutical Company Summary
7.3.2 Cubist Pharmaceutical Business Overview
7.3.3 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Major Product Offerings
7.3.4 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Cubist Pharmaceutical Key News & Latest Developments
7.4 Aridis Pharmaceutical
7.4.1 Aridis Pharmaceutical Company Summary
7.4.2 Aridis Pharmaceutical Business Overview
7.4.3 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Major Product Offerings
7.4.4 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Aridis Pharmaceutical Key News & Latest Developments
7.5 Valneva
7.5.1 Valneva Company Summary
7.5.2 Valneva Business Overview
7.5.3 Valneva Hospital Acquired Pneumonia Drugs Major Product Offerings
7.5.4 Valneva Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Valneva Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Hospital Acquired Pneumonia Drugs Major Product Offerings
7.6.4 Bayer Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hospital Acquired Pneumonia Drugs Major Product Offerings
7.8.4 Merck Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Achaogen
7.9.1 Achaogen Company Summary
7.9.2 Achaogen Business Overview
7.9.3 Achaogen Hospital Acquired Pneumonia Drugs Major Product Offerings
7.9.4 Achaogen Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Achaogen Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Hospital Acquired Pneumonia Drugs Major Product Offerings
7.10.4 AstraZeneca Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
8 Global Hospital Acquired Pneumonia Drugs Production Capacity, Analysis
8.1 Global Hospital Acquired Pneumonia Drugs Production Capacity, 2018-2029
8.2 Hospital Acquired Pneumonia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hospital Acquired Pneumonia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hospital Acquired Pneumonia Drugs Supply Chain Analysis
10.1 Hospital Acquired Pneumonia Drugs Industry Value Chain
10.2 Hospital Acquired Pneumonia Drugs Upstream Market
10.3 Hospital Acquired Pneumonia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hospital Acquired Pneumonia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hospital Acquired Pneumonia Drugs in Global Market
Table 2. Top Hospital Acquired Pneumonia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hospital Acquired Pneumonia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hospital Acquired Pneumonia Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Hospital Acquired Pneumonia Drugs Sales by Companies, (Kg), 2018-2023
Table 6. Global Hospital Acquired Pneumonia Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hospital Acquired Pneumonia Drugs Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Hospital Acquired Pneumonia Drugs Product Type
Table 9. List of Global Tier 1 Hospital Acquired Pneumonia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2018-2023
Table 15. By Type - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2024-2029
Table 16. By Application ? Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2018-2023
Table 20. By Application - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2024-2029
Table 21. By Region ? Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2018-2023
Table 25. By Region - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2024-2029
Table 26. By Country - North America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2018-2023
Table 29. By Country - North America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2024-2029
Table 30. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hospital Acquired Pneumonia Drugs Sales, (Kg), 2018-2023
Table 33. By Country - Europe Hospital Acquired Pneumonia Drugs Sales, (Kg), 2024-2029
Table 34. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hospital Acquired Pneumonia Drugs Sales, (Kg), 2018-2023
Table 37. By Region - Asia Hospital Acquired Pneumonia Drugs Sales, (Kg), 2024-2029
Table 38. By Country - South America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2018-2023
Table 41. By Country - South America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2024-2029
Table 42. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, (Kg), 2018-2023
Table 45. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, (Kg), 2024-2029
Table 46. Basilea Pharmaceutica Company Summary
Table 47. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Product Offerings
Table 48. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Basilea Pharmaceutica Key News & Latest Developments
Table 50. Meiji Holdings Company Summary
Table 51. Meiji Holdings Hospital Acquired Pneumonia Drugs Product Offerings
Table 52. Meiji Holdings Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. Meiji Holdings Key News & Latest Developments
Table 54. Cubist Pharmaceutical Company Summary
Table 55. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Product Offerings
Table 56. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 57. Cubist Pharmaceutical Key News & Latest Developments
Table 58. Aridis Pharmaceutical Company Summary
Table 59. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Product Offerings
Table 60. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 61. Aridis Pharmaceutical Key News & Latest Developments
Table 62. Valneva Company Summary
Table 63. Valneva Hospital Acquired Pneumonia Drugs Product Offerings
Table 64. Valneva Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 65. Valneva Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Hospital Acquired Pneumonia Drugs Product Offerings
Table 68. Bayer Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Product Offerings
Table 72. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Hospital Acquired Pneumonia Drugs Product Offerings
Table 76. Merck Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Achaogen Company Summary
Table 79. Achaogen Hospital Acquired Pneumonia Drugs Product Offerings
Table 80. Achaogen Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 81. Achaogen Key News & Latest Developments
Table 82. AstraZeneca Company Summary
Table 83. AstraZeneca Hospital Acquired Pneumonia Drugs Product Offerings
Table 84. AstraZeneca Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 85. AstraZeneca Key News & Latest Developments
Table 86. Hospital Acquired Pneumonia Drugs Production Capacity (Kg) of Key Manufacturers in Global Market, 2021-2023 (Kg)
Table 87. Global Hospital Acquired Pneumonia Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Hospital Acquired Pneumonia Drugs Production by Region, 2018-2023 (Kg)
Table 89. Global Hospital Acquired Pneumonia Drugs Production by Region, 2024-2029 (Kg)
Table 90. Hospital Acquired Pneumonia Drugs Market Opportunities & Trends in Global Market
Table 91. Hospital Acquired Pneumonia Drugs Market Drivers in Global Market
Table 92. Hospital Acquired Pneumonia Drugs Market Restraints in Global Market
Table 93. Hospital Acquired Pneumonia Drugs Raw Materials
Table 94. Hospital Acquired Pneumonia Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Hospital Acquired Pneumonia Drugs Downstream
Table 96. Hospital Acquired Pneumonia Drugs Downstream Clients in Global Market
Table 97. Hospital Acquired Pneumonia Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hospital Acquired Pneumonia Drugs Segment by Type in 2022
Figure 2. Hospital Acquired Pneumonia Drugs Segment by Application in 2022
Figure 3. Global Hospital Acquired Pneumonia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Pneumonia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hospital Acquired Pneumonia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Hospital Acquired Pneumonia Drugs Sales in Global Market: 2018-2029 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Hospital Acquired Pneumonia Drugs Revenue in 2022
Figure 9. By Type - Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Hospital Acquired Pneumonia Drugs Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Hospital Acquired Pneumonia Drugs Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 23. US Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 28. Germany Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 37. China Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hospital Acquired Pneumonia Drugs Production Capacity (Kg), 2018-2029
Figure 53. The Percentage of Production Hospital Acquired Pneumonia Drugs by Region, 2022 VS 2029
Figure 54. Hospital Acquired Pneumonia Drugs Industry Value Chain
Figure 55. Marketing Channels
